Earnings ·
Artivion reports Q3 revenue of $123.8M and narrows full-year guidance to $484-$492M
AORTArtivion, Inc.
Artivion reported third-quarter revenue of $123.8 million, a 9% increase from the prior year period. The company posted a GAAP net loss of $(7.9) million, or $(0.16) per diluted share, compared to a net income of $6.5 million in the same quarter last year. Non-GAAP net income was $3.8 million, or $0.08 per diluted share. Adjusted EBITDA declined 8% to $22.5 million. Management narrowed its full-year 2026 revenue guidance to a range of $484 to $492 million and adjusted EBITDA expectations to $93 to $98 million. Artivion is a medical device company focused on developing solutions for cardiac and vascular surgeons treating patients with aortic diseases.